A 16-amino-acid peptide, MOTS-c is unique and unlike most mitochondrial proteins that are nuclear-encoded and imported into the organelle. It originates endogenously and nuclearly translocates, serving as a retrograde signal. MOTS-c is derived from within the mitochondria and is directly transcribed plus translated from the mitochondrial genome—making it a significant bioactive-signaling molecule encoded within the mitochondrial 12S rRNA region of mtDNA.
The bioactivity of MOTS-c is based on its ability to modulate various metabolic activities and several stress-responsive pathways, particularly those that involve the following interactions:
Significantly, MOTS-c has been shown to activate AMPK, an enzymatic, critical energy sensor that senses and promotes catabolic pathways (e.g., fatty acid oxidation) and inhibits anabolic inputs (e.g., lipogenesis) in response to low cellular energy. By enhancing AMPK activity, MOTS-c facilitates functions ranging from lipolysis to catabolism. Additionally, the peptide agent increases glucose uptake in skeletal muscle, enhances fatty acid oxidation, improves mitochondrial oxidative capacity, and reduces adipogenesis. In turn, this metabolic shift supports more Adenosine Triphosphate or ATP generation and also contributes to improved cellular energy balance and efficiency.
MOTS-c reinforces insulin sensitivity through its boosting of GLUT4 translocation and improving insulin receptor substrate (IRS) signaling. Its additive effect on insulin action is entwined and synergistic with AMPK activation, which simultaneously reduces hepatic gluconeogenesis and improves glucose clearance in peripheral tissues. This peptide contributes to and helps maintain metabolic homeostasis, and harnesses blood sugar balance.
In folate cycle modulation, MOTS-c demonstrates a function in the folate-dependent de novo purine biosynthesis pathway. It delivers nucleotide synthesis maintenance, and strategically promotes cellular proliferation in cases of nutrient-deficient conditions.
A mitochondrial homeostasis support, MOTS-c enhances mitochondrial efficiency by mobilizing mitochondrial biogenesis, developing antioxidant defenses, and facilitating mitophagy or deletion of dysfunctional mitochondria.
Metabolic flexibility is the capacity of cells to switch between fuel sources (e.g., glucose and fatty acids) based on availability and demand. MOTS-c advances this transition by boosting fat oxidation when fasting, optimizing mitochondrial adaptability to substrate availability, and more.
Mitochondrial-derived peptides or MDPs are small bioactive molecules encoded within the mitochondrial genome that play key roles in cellular signaling, metabolism, and stress response. They represent a novel class of endogenous regulators that help maintain mitochondrial and metabolic health.
Some mitochondrial peptides, including MOTS-c, can translocate from the mitochondria to the nucleus, where they modulate gene expression in response to cellular energy status or stress. This mitochondrial-nuclear crosstalk is essential for coordinated cellular adaptation.
Mitochondrial peptides have been shown to influence pathways involved in insulin sensitivity, fat metabolism, and oxidative stress, making them promising targets in understanding and potentially managing metabolic diseases such as diabetes, obesity, and metabolic syndrome.
Yes. Mitochondrial peptides like MOTS-c regulate key energy-sensing pathways such as AMPK, helping cells adapt to energy demands by promoting catabolic processes and inhibiting anabolic pathways when energy is low, thus maintaining overall metabolic efficiency.
Levels of certain mitochondrial peptides decline with age, which may impair mitochondrial function and metabolic regulation. This decline is associated with reduced cellular resilience and increased susceptibility to metabolic dysfunction, highlighting their potential role in healthy aging.
MOTS-c represents a novel class of mitochondrial-derived peptides with significant implications for metabolic regulation. By enhancing mitochondrial efficiency, supporting insulin action, and promoting energy adaptation, MOTS-c serves as a key mediator in maintaining cellular and systemic metabolic balance. Its ability to bind to critical signaling pathways such as AMPK and influence glucose and lipid metabolism highlights its potential as a valuable target in metabolic research. As the scientific community continues to explore mitochondrial signaling in greater depth, MOTS-c may help redefine how we approach mitochondrial health and metabolic efficiency from a cellular signaling perspective.
Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S., Mehta, H., Hevener, A. L., De Cabo, R., & Cohen, P. (2015b). The Mitochondrial-Derived Peptide MOTS-C promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454. https://doi.org/10.1016/j.cmet.2015.02.009
Author
Janelle A.